All In Biotech

Drug Trial Radar · NCT07358858

A Food Effect Study of QLS1410 in Healthy Chinese Adults

A Randomized, Open-label, Two-period, Crossover Food Effect Study of QLS1410 in Healthy Chinese Adults

Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

Jan 23, 2026

Primary completion

Feb 7, 2026

Study completion Feb 7, 2026

Sponsor

Lead sponsor
Qilu Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Jan 22, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is aimed to evaluate the effect of food on pharmacokinetics of QLS1410 in healthy Chinese adults.

Conditions

  • Uncontrolled Hypertension

Interventions

  • QLS1410Drug

    QLS1410 tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUC0-∞Time frame: 0 to 96 hours
  2. Area under the curve plasma concentration from time zero to Time of Last Quantifiable ConcentrationTime frame: 0 to 96 hours
  3. Maximum observed plasma concentrationTime frame: 0 to 96 hours

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.